|Bid||76.50 x 1200|
|Ask||78.00 x 1100|
|Day's range||76.52 - 79.07|
|52-week range||43.40 - 90.15|
|Beta (5Y monthly)||1.23|
|PE ratio (TTM)||12.28|
|Earnings date||30 Jul 2020 - 03 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||85.17|
Dialysis is the process of using a medical circulation device (either at home or at a clinic) to substitute kidney functions for patients with end-stage kidney failure. Each year, over 100,000 Americans with new cases of renal failure visit dialysis clinics to receive appropriate treatment. Since the full cost of dialysis treatments is reimbursed by the U.S. government, a wave of providers has moved to capitalize on the opportunity.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Image source: The Motley Fool. DaVita (NYSE: DVA)Q1 2020 Earnings CallMay 05, 2020, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, good evening.
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 25.34% and 0.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Below are three stocks Berkshire holds that can be great additions to your portfolio today. The company's coming off a strong 2019, in which its adjusted per-share profits were $5.40, well above the $3.57 it reported for the previous year. On DaVita's earnings call in February, CFO Joel Ackerman projected even more growth for 2020, expecting adjusted EPS to fall between $5.75 and $6.25.
DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DaVita (DVA) continues to gain traction from strong international foothold, strategic buyout of dialysis centers and DaVita Kidney Care.
Zacks.com featured highlights include: ITOCHU, Am??rica M??vil, Donegal, DaVita and The Cardinal Health